Allogenic Transplant clinical trials at UCSF
1 research study open to eligible people
Donor cells are used in allogenic transplants to replace a patient's damaged cells. UCSF has a trial to evaluate an oral drug's safety for cancer patients getting stem cell transplants. Researchers are testing how well this drug works when taken with antibiotic protection before the transplant.
Showing trials for
Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant
open to eligible people ages 18 years and up
This is a Phase 1b/2a study in allogenic hematopoietic stem cell transplant patients to investigate the safety, PK, PD and preliminary efficacy of multiple oral administrations of SNIPR001 when given concomitantly with SoC levofloxacin.
San Francisco, California and other locations
Last updated: